PROJECT

Projects

Summary of Investment Information

Project Number

49897

Company Name

Shandong Weigao Group Medical Polymer Co., Ltd.

Date SPI Disclosed

Jan 16, 2025

Country

East Asia and Pacific Region

Region

East Asia and the Pacific

Projected Board Date

Nov 29, 2024

Environmental Category

B - Limited

Status

Active

Last Updated Date

Apr 30, 2025

Department

CM4S2 - Regional Industry - MAS Asia & Pac/MAS Services, EAP

Industry

other

Previous Events

Approved : Dec 3, 2024
Signed : Dec 6, 2024
Invested : Apr 24, 2025

Sector

other

Project Description

 

Shandong Weigao Group Medical Polymer Co., Limited (“Weigao” or the “Company”) is a leading manufacturer of single-use medical consumables in China. The proposed investment is a debt financing package including up to US$250 million equivalent IFC A Loan to support Weigao in (i) expanding manufacturing capacity in consumables products in China; (ii) expanding into Southeast Asia, especially in Indonesia, through enhanced sales and marketing activities and localization of product manufacturing; and (iii) new product R&D to expand its product offerings including chronic disease management and health informatics (the “Project”).

 

Associated Advisory Engagement

None.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation